Clinical Trials Browser

Phase 1 × Has results × radium Ra 223 dichloride × Clear all

NCT03996473 2024-10-10

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Phase 1 Terminated

8 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung